Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health Outcomes

12. november 2026 oppdatert av: The Collagen Co. - GLP-1 Users

This is a single-group, open-label, decentralized clinical trial evaluating the effects of 6 weeks of daily Glow Shakes Premium Collagen Meal Replacement consumption on body composition, weight management, and self-reported health outcomes in 40 adults aged 18-55 years with a BMI between 25-35 kg/m².

All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily, replacing two typical meals, for 6 consecutive weeks. Assessments will be conducted at Baseline, Week 2, Week 4, and Week 6 and will include validated self-report questionnaires and body composition measurements via the Withings smart scale. All study activities are conducted remotely; products are shipped directly to participants' homes and all data are submitted digitally through the Citruslabs study platform.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

40

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Nevada
      • Las Vegas, Nevada, Forente stater, 89101
        • Citruslabs

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 55 år (Voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Adults aged 18-55 years at the time of enrollment.
  • BMI between 25-35 kg/m² at screening, as confirmed via participant self-report and/or Withings smart scale measurement at Baseline.
  • Self-reported goals around weight management, body composition improvement, or overall health and wellness at the time of enrollment.
  • Willing and able to use Glow Shakes Premium Collagen Meal Replacement as a daily meal replacement (replacing two typical meals) for 6 consecutive weeks and to complete all questionnaire assessments and Withings smart scale body composition measurements at Baseline, Week 2, Week 4, and Week 6.
  • Willing to maintain current diet (except for the test product), exercise routine, and lifestyle habits for the duration of the 6-week study, without introducing any new supplements or products specifically targeting weight loss, appetite, or body composition.
  • In good general health.
  • Resides in the United States.

Exclusion Criteria:

  • Pregnant or breastfeeding at the time of enrollment, or planning to become pregnant during the 6-week study period.
  • Currently using GLP-1 receptor agonists, dual-incretin medications, prescription weight loss drugs, or any other prescription medication directly affecting appetite or body weight.
  • Known allergy or intolerance to any ingredient in the Glow Shakes formulation, including milk protein, whey protein, or collagen-derived (bovine) ingredients.
  • Diagnosed with a serious medical condition requiring medical nutritional management, including but not limited to Type 1 diabetes, active cancer, or severe renal or hepatic disease.
  • Currently testing, or plan to in the next 6 weeks, a product for another research study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Glow Shakes Premium Collagen Meal Replacement Arm

All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily (replacing two meals) for 6 weeks. Assessments will be conducted at four timepoints: Baseline, Week 2, Week 4, and Week 6. Assessments will include validated self-report questionnaires and body composition measurements via the Withings smart scale.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Body Weight
Tidsramme: Baseline to Week 6

Change in body weight (kg) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home)

Baseline to Week 6
Change in Body Fat Percentage
Tidsramme: Baseline to Week 6

Change in body fat percentage (%) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home)

Baseline to Week 6

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Self-Reported Weight Management Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported weight management scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Hunger Intensity
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported hunger intensity as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Satiety Duration
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported satiety duration as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Food Craving Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported food craving scores as assessed via the Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced)

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Skin Health Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported skin health scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Hair Health Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported hair health scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Nail Health Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported nail health scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Gut Comfort and Digestive Symptom Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported gut comfort and digestive symptom scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Participant-Reported Product Satisfaction
Tidsramme: Week 6

Participant-reported product satisfaction, acceptability, and tolerability as assessed via product satisfaction questionnaire

Week 6
Participant-Reported Product Tolerability
Tidsramme: Week 6

Participant-reported tolerability of the study product as assessed via product satisfaction questionnaire

Week 6
Participant-Reported Overall Product Experience
Tidsramme: Week 6

Participant-reported overall experience with the study product as assessed via product satisfaction questionnaire

Week 6

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Samarbeidspartnere

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. november 2026

Primær fullføring (Antatt)

1. februar 2027

Studiet fullført (Antatt)

1. februar 2027

Datoer for studieregistrering

Først innsendt

12. november 2026

Først innsendt som oppfylte QC-kriteriene

12. november 2026

Først lagt ut (Faktiske)

18. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

12. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • THECO-22384

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .